Kostas D Odysseas's Net Worth
$2.3 Million
Who is Kostas D Odysseas?
Kostas D Odysseas has an estimated net worth of $2.3 Million. This is based on reported shares across multiple companies, which include Innoviva, Inc., Sarissa Capital Acquisition Corp., ENZON PHARMACEUTICALS INC, ADVENTRX PHARMACEUTICALS INC, Armata Pharmaceuticals, Inc., and AMARIN CORP PLC\UK.
SEC CIK
Kostas D Odysseas's CIK is 0001483080
Past Insider Trading and Trends
2023 was Kostas D Odysseas's most active year for acquiring shares with 7 total transactions. Kostas D Odysseas's most active month to acquire stocks was the month of March. 2022 saw Kostas D Odysseas paying a total of $10,000.00 for 55,647 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Innoviva, Inc. (INVA) Snapshot price: $18.7201
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.81% | 13.92K |
—
|
—
| 122.63K |
Jun 17
| |||
Form 4
| +17.89% | 16.5K |
—
|
—
| 108.7K |
May 22
| |||
Form 4
| +15.90% | 12.65K |
—
|
—
| 92.21K |
Apr 25
| |||
Form 4
| +28.16% | 17.48K |
—
|
—
| 79.56K |
May 14
| |||
Form 4
| +37.46% | 16.92K |
—
|
—
| 62.08K |
Apr 24
| |||
Form 4
| +57.02% | 16.4K |
—
|
—
| 45.16K |
Apr 24
| |||
Form 4
| +98.18% | 14.25K |
—
|
—
| 28.76K |
Apr 24
| |||
Form 4
|
∞
| 14.51K |
—
|
—
| 14.51K |
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sarissa Capital Acquisition Corp. No price found
Senior Managing Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADVENTRX PHARMACEUTICALS INC (SVRA) Snapshot price: $4.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Armata Pharmaceuticals, Inc. (ARMP) Snapshot price: $2.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||